## Abstract We propose a method for calculating the production costs of an intervention in a manner that accounts for differences in productive ‘effort.’ This method could be used within a cost‐effectiveness analysis framework in the evaluation of new medical technologies, pharmaceuticals, treatmen
Biases in cost measurement for economic evaluation studies in health care
✍ Scribed by Philip Jacobs; Jean-François Baladi
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 401 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1057-9230
No coin nor oath required. For personal study only.
✦ Synopsis
This paper addresses the issue of biases in cost measures which are used in economic evaluation studies. The basic measure of hospital costs which is used by most investigators is unit cost. Focusing on this measure, a set of criteria which the basic measures must fulfil in order to approximate the marginal cost (MC) of a service for the relevant product, in the representative site, was identified. Then four distinct biases-a scale bias, a case mix bias, a methods bias and a site selection bias-each of which reflects the divergence of the unit cost measure from the desired MC measure, were identified. Measures are proposed for several of these biases and it is suggested how they can be corrected.
📜 SIMILAR VOLUMES
## Abstract In the economic evaluation of health care programmes, productivity costs are often estimated using patients' wages for the period of absence. However, the use of such methods for short periods of absence is controversial. A previous study found that short‐term absence is often compensat
To date, a common view in the health economics literature is that the applicability of cost-benefit analysis (CBA) is limited, due to the distribution problem which underlies its main method of valuation (e.g. willingness to pay). One view is that cost effectiveness analysis (CEA) overcomes these pr
Discounting costs and health benefits in cost-effectiveness analysis has been the subject of recent debate -some authors suggesting a common rate for both and others suggesting a lower rate for health. We show how these views turn on key judgments of fact and value: on whether the social objective i
## Abstract __Background__: A reproducible observation is that consumers' willingness‐to‐accept (WTA) monetary compensation to forgo a program is greater than their stated willingness‐to‐pay (WTP) for the same benefit. Several explanations exist, including the psychological principle that the utili
## Abstract There are strong theoretical arguments for including future costs for related and unrelated medical care and non‐medical expenditures within economic evaluations. Nevertheless, there is limited data on how inclusion of such costs affects the cost effectiveness of medical interventions i